Table 1: Salient clinical characteristics of the 14 infants.

PatientGenderAge (month)LocalisationSize (cm)FRNb TI (week)FU (month)AECutoff F FlNb PAdd T

1F3.5Scalp and foot1.5N4210Cr550–59030–512–6N
2F3.5Neck5P, Bl32–410N55026–3010–15Oral CS
3F3CheekNSN42-330N590423N
4F7.5Chin2.5N54–1624N59026–422–6N
5F7.5BackNSN43-466Bl, Ulc59030–514–8N
6M1.7Thigh and forearmNSN31-22.3Cr5904610–14N
7F2.8Forehead0.8N13N590451N
8M5Cheek,
forearm,
back, and scalp
NSN3311N59045–483–5N
9M2.5Ear meatus3.5N15.6N590444N
10F1.4Scalp1.5N32–123.5N590453N
11F8EyebrowNSN44–816N55026–382N
12M5NoseNSBl15N550283N
13F3.5NSNSN64–810.5N550–59036–511N
14M12Back and handNSN25224N55026–321–3N

Age = at first visit; FR = functional repercussion (at the time patient was seen)
Nb T, I = number of treatments, interval; FU = followup (= last seen at the age mentioned); AE = adverse events
cutoff F, Fl, Nb P = cutoff filters (nm), fluence (J/cm²), number of pulses per treatment; Add T = additional treatment
F = female; M = male; N = none; NS = not specified, C = clearance
P = pain; Bl = bleeding; Ulc = ulceration; Tel = telangiectasias; Cr = crusts
CS = corticosteroids.